Galmed Pharmaceuticals Ltd. buy BTIG Research
Start price
18.03.24
/
50%
€0.30
Target price
18.03.25
€55.09
Performance (%)
2062.16%
End price
19.03.25
-
Summary
This prediction is currently being closed. With a performance of 2062.16% the BUY prediction by BTIG_Research is a big success. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | 4,85 % | -2,75 % | 13,10 % |
| iShares Nasdaq 100 | 4,00 % | -3,33 % | 31,34 % |
| iShares Nikkei 225® | 4,22 % | -2,91 % | 44,47 % |
| iShares S&P 500 | 3,32 % | -2,95 % | 24,36 % |
Comments by BTIG_Research for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $60.00 price target on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten
Stopped prediction by BTIG_Research for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
12.12.24
12.12.24
€86.70
12.12.25
12.12.25
-
13.12.25
13.12.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
14.10.24
14.10.24
€71.53
14.10.25
14.10.25
-
15.10.25
15.10.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.24
28.08.24
28.08.24
€69.28
28.08.25
28.08.25
2589.08%
29.08.25
29.08.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.27
16.07.24
16.07.24
€68.81
16.07.25
16.07.25
-15.56%
17.07.25
17.07.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.33
29.05.24
29.05.24
€66.36
29.05.25
29.05.25
1827.71%
30.05.25
30.05.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.36
08.05.24
08.05.24
€58.61
08.05.25
08.05.25
1667.96%
09.05.25
09.05.25

